-
Tuesday, 16 February 2021 07:00SparingVision Conference Participation in H1 2021
SparingVision announces the conferences that its management team will be participating in in the first half of 2021.
Thursday, 04 February 2021 07:00Dr. Daniel C. Chung appointed as Chief Medical Officer of SparingVisionFormer Spark Therapeutics head of ophthalmic medical affairs, responsible for the development and approval of Luxturna™, to lead development of SparingVision’s proprietary asset, SPVN06, and further pipeline development
Monday, 01 February 2021 07:00Renowned Pioneers in Ophthalmology Join SparingVision’s Scientific Advisory BoardDevelopment of lead asset SPVN06 to further benefit from high-level Clinical Advisory Board
Thursday, 29 October 2020 08:00SparingVision Strengthens Management TeamWednesday, 21 October 2020 07:00SparingVision Raises €44.5 Million and Appoints Stéphane Boissel as Chief Executive OfficerTuesday, 30 June 2020 08:00SparingVision Receives European Orphan Designation for its Drug Candidate SPVN06 Dedicated to Inherited Retinal DystrophiesTuesday, 03 December 2019 07:00SparingVision wins First Prize at EIT European Health Catapult competitionThursday, 25 July 2019 08:00SparingVision to Present at the Ophthalmology Innovation Summit (OIS) in Chicago on July 25th, 2019 during the American Society of Retinal Specialists (ASRS) meetingFriday, 05 July 2019 08:00SparingVision awarded at EIC Accelerator program (H2020 SME instrument Phase 2), securing funding of €2.5 millionThursday, 04 July 2019 08:00SparingVision sélectionnée au programme européen EIC Accelerator (H2020 SME instrument Phase 2) pour un financement de 2,5 millions d’eurosThursday, 25 April 2019 08:00SparingVision to present preclinical datas for Retinitis Pigmentosa’s treatment during Annual Congress of the Association for Research in Vision and Ophthalmology (ARVO)Tuesday, 26 February 2019 07:00Journée Internationale des Maladies RaresTuesday, 05 February 2019 07:00SparingVision récompensée par le « Mercure des Entrepreneurs HEC 2019 » dans la catégorie « Création d’Entreprise »Tuesday, 09 January 2018 07:00SparingVision sélectionnée pour une présentation publique au 10e Biotech Showcase™Monday, 08 January 2018 07:00SparingVision to Participate in the 10th Annual Biotech Showcase in San Francisco,Wednesday, 12 July 2017 08:001 For Release: July 12, 2017 Contact: Rhea Farberman, Foundation Fighting Blindness 410-423-0635 SparingVision Wins Grand Prize of 2017 i-Lab Contest for New, Innovative French Companies
Press releases